- Report
- August 2025
- 193 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- January 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- July 2023
- 110 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- May 2023
- 96 Pages
Asia Pacific
From €1613EUR$1,800USD£1,384GBP
From €1613EUR$1,800USD£1,384GBP
- Report
- May 2023
United States
From €1344EUR$1,500USD£1,153GBP
- Report
- April 2021
- 377 Pages
Global
From €3580EUR$3,995USD£3,072GBP
- Report
- March 2021
Global
From €3361EUR$3,750USD£2,883GBP
- Report
- January 2023
- 343 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- March 2025
- 294 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- January 2025
- 291 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- January 2025
- 286 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- August 2025
- 82 Pages
India
From €3137EUR$3,500USD£2,691GBP
- Report
- May 2025
- 180 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- April 2025
- 85 Pages
India
From €3137EUR$3,500USD£2,691GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3137EUR$3,500USD£2,691GBP
- Report
- September 2024
- 82 Pages
Japan
From €3137EUR$3,500USD£2,691GBP
- Report
- October 2023
- 128 Pages
North America
From €3585EUR$4,000USD£3,075GBP
- Report
- October 2023
- 178 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- August 2025
- 188 Pages
Global
From €4033EUR$4,500USD£3,460GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more